Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have issued a buy […]

Shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has given a strong buy recommendation […]